2nd Quarter - Report
INVARIANT LLC for ELI LILLY AND COMPANY
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
H.R. 5629, Pathway for Biosimilars Act; H.R. 1038/S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007; S. 1505, Affordable Biologics for Consumers Act; S. 1695, Biologics Price Competition and Innovation Act of 2007, as they pertain to the term of data exclusivity for biologic drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIAN A HAYWOOD | Legislative Assistant, Rep. Julian Dixon |
| HEATHER PODESTA | Research Assistant, Congressional Budget Office |
| STACY STORDAHL | Staff Assistant, Senator Donald Riegle, Jr. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.